SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA (1282)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-proteinase-3 (Pr-3) antibodies (K010287 | K010287) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Abbott COMMANDER SystemView Complexity
TECHNICON RA 1000View Complexity
Roche Diagnostics Cobas Mira PlusView Complexity
Centocor CAPTIA Toxo-GView Complexity
BioWhittaker RheumELISA IIView Complexity
Phadia ImmunoCAP 100View Complexity
Roche Diagnostics MODULAR ANALYTICS E170 AnalyzerView Complexity
Immunicon CellTracks Analyzer II and CellTracks AutoPrep SystemView Complexity
BioHyTech EIA KitView Complexity
Olympus AU680 Clinical Chemistry AnalyzerView Complexity